Retatrutide for Weight Loss (LY3437943)
What is Retatrutide Retatrutide is an investigational drug being developed by Eli Lilly and Company for the treatment of obesity and type 2 diabetes. Retatrutide is developed under the name LY3437943 Retatrutide Timeline So Far Retatrutide first entered clinical trials in the year 2021. This initial phase of clinical trials was an important step in […]
Retatrutide for Weight Loss (LY3437943) Read More »